Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study)

Mitsuyasu Itoh; Atsushi Suzuki; Taiya Katoh; Yoshikuni Sawai; Shogo Asano; Shigeo Imamura; Yoshinari Hayashi; Shinobu Goto; Nobuo Takahashi; Tetsuya Kawabe

doi:10.20407/fmj.2019-023

Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study)

Mitsuyasu Itoh
, Atsushi Suzuki
, Taiya Katoh
, Yoshikuni Sawai
, Shogo Asano
, Shigeo Imamura
, Yoshinari Hayashi
, Shinobu Goto
, Nobuo Takahashi
, Tetsuya Kawabe

Department of Endocrinology, Diabetes and Metabolism

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	Fujita Medical Journal
Volume	7
Issue number	1
DOIs	https://doi.org/10.20407/fmj.2019-023
Publication status	Published - 01-02-2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.20407/fmj.2019-023

Cite this

Itoh, M., Suzuki, A., Katoh, T., Sawai, Y., Asano, S., Imamura, S., Hayashi, Y., Goto, S., Takahashi, N., & Kawabe, T. (2021). Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study). Fujita Medical Journal, 7(1), 1-7. https://doi.org/10.20407/fmj.2019-023

Itoh, Mitsuyasu ; Suzuki, Atsushi ; Katoh, Taiya et al. / Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study). In: Fujita Medical Journal. 2021 ; Vol. 7, No. 1. pp. 1-7.

@article{060bf1478cfc41e9ae7f8512f5ebaa99,

title = "Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study)",

author = "Mitsuyasu Itoh and Atsushi Suzuki and Taiya Katoh and Yoshikuni Sawai and Shogo Asano and Shigeo Imamura and Yoshinari Hayashi and Shinobu Goto and Nobuo Takahashi and Tetsuya Kawabe",

year = "2021",

month = feb,

day = "1",

doi = "10.20407/fmj.2019-023",

language = "English",

volume = "7",

pages = "1--7",

journal = "Fujita Medical Journal",

issn = "2189-7247",

publisher = "Fujita Medical Society",

number = "1",

}

Itoh, M, Suzuki, A, Katoh, T, Sawai, Y, Asano, S, Imamura, S, Hayashi, Y, Goto, S, Takahashi, N & Kawabe, T 2021, 'Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study)', Fujita Medical Journal, vol. 7, no. 1, pp. 1-7. https://doi.org/10.20407/fmj.2019-023

Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study). / Itoh, Mitsuyasu; Suzuki, Atsushi; Katoh, Taiya et al.
In: Fujita Medical Journal, Vol. 7, No. 1, 01.02.2021, p. 1-7.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study)

AU - Itoh, Mitsuyasu

AU - Suzuki, Atsushi

AU - Katoh, Taiya

AU - Sawai, Yoshikuni

AU - Asano, Shogo

AU - Imamura, Shigeo

AU - Hayashi, Yoshinari

AU - Goto, Shinobu

AU - Takahashi, Nobuo

AU - Kawabe, Tetsuya

PY - 2021/2/1

Y1 - 2021/2/1

U2 - 10.20407/fmj.2019-023

DO - 10.20407/fmj.2019-023

M3 - Article

SN - 2189-7247

VL - 7

SP - 1

EP - 7

JO - Fujita Medical Journal

JF - Fujita Medical Journal

IS - 1

ER -

Itoh M, Suzuki A, Katoh T, Sawai Y, Asano S, Imamura S et al. Comparative study of the usefulness of a novel insulin therapy in Japanese patients with Type 2 diabetes for concomitant use of an oral antidiabetic agent with twice-daily dosing either of insulin aspart, biphasic insulin aspart-30, or insulin detemir: Two times Insulin injection Combined with oral therapy Efficacy Study (TWICE study). Fujita Medical Journal. 2021 Feb 1;7(1):1-7. doi: 10.20407/fmj.2019-023